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NOTE
IN VITRO FERTILIZATION, FERTILITY
FRUSTRATIONS, AND THE LACK OF
REGULATION
I.

INTRODUCTION

Airing from 2014 to 2019, The CW's Jane the Virgin depicted the
life of a "young, devout Catholic woman" after she discovered she had
been "mistakenly artificially inseminate[d]" by her doctor during a
routine check-up.' Audiences watched as the heroine, Jane, navigated a
relationship with the biological father of the baby.2 The baby's
biological father happened to be a married man, a former playboy, and
Jane's boss.3 Jane also had to balance this nuanced relationship with
others, including the ones she maintained with her boyfriend and her
involved and extremely invested family.4 The series was nominated for
four Golden Globes and won one over the course of its airing.5 Critics
hailed it as "a show that shouldn't be taken for granted."6 While Jane's
medical mix-up was literally made for television, such a shocking
7
narrative is not unheard of in reality beyond broadcast entertainment.
1. See generally Jane the Virgin, IMDB, https://www.imdb.com/title/tt3566726 (last visited
Feb. 8, 2021) [hereinafter Jane the Virgin Description] (providing a plot summary of the television
series); Jane the Virgin (The CW television broadcast 2014). Another television broadcast that
utilized artificial insemination to develop the show's plot is NBC's The Office, which depicted an
erratic female character shocking her previous boyfriend when she revealed she had visited a sperm
bank, unbeknownst to him, to pursue artificial insemination during the course of their relationship.
The Office: Goodbye, Toby (NBC television broadcast May 15, 2008); Season 4 - Episode 14
"Goodbye Toby," OFFICEQUOTES.NET, https://www.officequotes.net/no4-14.php (last visited Feb. 8,
2021).
2. Jane the Virgin, supra note 1.

3. Jane the Virgin Description, supra note 1.
4. Id.
5. Winners & Nominees: Jane the Virgin, HFPA, https://www.goldenglobes.com/tvshow/jane-virgin (last visited Feb. 8, 2021).
6. Alessandra Stanley, 'Jane the Virgin' Ends a Strong First Season, N.Y. TIMES (May 10,
https://www.nytimes.com/2015/05/11/arts/television/jane-the-virgin-ends-a-strong-first2015),
season.html ("'Jane the Virgin' is an inspired swirl of Latin music, romance and telenovela kitsch
that takes its ethnic identity as a given.").
7. See Kathianne Boniello, Mom Whose Embryo Was Wrongly Implanted in Queens Woman
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Hopeful parents that have been tangled in medical mix-ups that involve
their biological child being inadvertently birthed by an unintended
woman have been left "hurt by these experiences in ways that haunt [the
biological parent] every day." 8 While Jane's fictional story yielded a
dramatic and enduring television series, pregnancies using the
reproductive technology that inadvertently caused Jane's pregnancy
have grown rapidly in reality and practice. 9 Preliminary data indicate
that "the number of [in vitro fertilization] cycles increased by 21% in
just one year, from 2012 to 2013."10 In fact, over one million babies
were born in the United States between 1987 and 2015 through the use
of some reproductive technology, including assistance from a fertility
doctor.1
The United States Centers for Disease Control and Prevention
("CDC") is responsible for reporting health information to the general
public.12 After compiling information regarding infertility in women, the
CDC reported: "Of the approximately 61 million women aged 15-44
years in 2011-2015, more than 7 million, or 12%, had received any
infertility services. Additionally, almost 7% of married women aged
15-44 years were unable to get pregnant after at least 12 consecutive
months of trying."" Hopeful parents who would like to pursue a
pregnancy aided by medical intervention have autonomy in choosing a

Tells All, N.Y. POST (July 13, 2019, 7:04 PM), https://nypost.com/2019/07/13/mom-whose-embryowas-wrongly-implanted-in-/queens-woman-tells-all (discussing a couple who was pursuing in vitro
fertilization ("IVF") in California and the couple's resulting shock when they were informed by the
fertility clinic that one of their embryos was wrongly implanted in a woman from New York, who
had already given birth to the child).
8. Isaac Stanley-Becker & Michael Brice-Saddler, They Thought Their Embryo Didn't Take.
Then Their Son Was Born to a Stranger Across the Country, Lawsuit Claims, WASH. POST (July 10,
2019, 6:41 PM), https://www.washingtonpost.com/nation/2019/07/10/they-thought-their-embryodidnt-take-then-their-son-was-born-stranger-across-country-lawsuit-claims/?noredirect=on.
9. Jane the Virgin Description, supra note 1; Ellie Kincaid, A Booming Medical Industry in

the US. Is Almost Totally Unregulated, BUS. INSIDER (July 7, 2015, 3:50
PM), https://www.businessinsider.com/assisted-reproduction-ivf-industry-regulation-2015-6.
10. Kincaid, supra note 9.
11. IVF by the Numbers, PENN MED.: FERTILITY BLOG (Mar.
14, 2018),
https://www.pennmedicine.org/updates/blogs/fertility-blog/2018/march/ivf-by-the-numbers.
12. Mission, Role and Pledge, CTRS. FOR DISEASE CONTROL & PREVENTION,
https://www.cdc.gov/about/organization/mission.htm (May 13, 2019).
13. CTRS.
TECHNOLOGY:

FOR DISEASE CONTROL
FERTILITY
CLINIC

& PREVENTION, 2017 ASSISTED
SUCCESS
RATES
REPORT

REPRODUCTIVE
3
(2019),

ftp://ftp.cdc.gov/pub/Publications/art/ART-2017-Clinic-Report-Full.pdf. For "many people who
want to start a family, the dream of having a child is not easily realized." Id. at 1. "Infertility is 'the
inability to conceive [a child] after 12 months of unprotected intercourse,"' or after six months if the
woman

is thirty-five years or older. Defining Infertility, AM. SOC'Y FOR REPROD. MED.,

https://www.reproductivefacts.org/news-and-publications/patient-fact-sheets-andbooklets/documents/fact-sheets-and-info-booklets/defining-infertility (last visited Feb. 8, 2021).
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clinic and doctor that they trust to facilitate this process.14 Many
decisions go into choosing the doctors, researchers, and methods
involved with such an intimate procedure." The U.S. government has
enacted a statute that intends to provide hopeful parents with information
that can be useful in selecting a clinic to help propel a pregnancy. 16 This
information can include data regarding the particular assisted
reproductive method or methods employed at the clinic in question, the
reasons for the usage of assisted reproductive technology ("ART") by a
clinic's patients, and the success rate based on the service provided.' 7
Therefore, although not required to do so, clinics have some incentive to
provide the success rates of reproductive methods utilized by their
practice over the previous year.1 8 Even though the federally regulated
data is useful and supports success rates, patients still cannot obtain all
the information they need because of issues associated with
transparency, or the lack thereof.19
Part II of this Note will begin by examining the history and
background behind reproductive technologies, including one in
particular: in vitro fertilization ("IVF" ). 2 Developments in reproductive
technology and their related history were catalysts for the existing U.S.

14. See generally, e.g., Natalie Silverman, Would You Go to IVF Bootcamp?, THE FERTILITY
PODCAST (Aug. 12, 2019) (downloaded using Apple Podcasts) (showcasing one conversation with a
fertility clinician who offers intensive fertility treatment, colloquially known as "bootcamp"); About
Me, THE FERTILITY PODCAST, https://www.thefertilitypodcast.com/about (last visited Feb. 8, 2021)

(hosting fertility experts, medical directors, pharmacists, consultants, and celebrities as guest
podcast panelists to discuss miscarriage and fertility treatments).
15. See generally About Me, supra note 14 (showcasing opportunities to hear and observe
conversations regarding fertility treatment by experts in the field).
16. See generally Fertility Clinic Success Rate and Certification Act of 1992, Pub. L. No.
102-493, 106 Stat. 3146 (codified as amended at 42 U.S.C. §§ 263a-1-a-7) (setting forth required
reporting statistics for embryo laboratories).
17. CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 13.
18. Laura Damiano, Note, When Parents Can Choose to Have the "Perfect" Child: Why
Fertility Clinics Should Be Required to Report PreimplantationGenetic Diagnosis Data, 49 FAM.

CT. REV. 846, 853-54 (2011) (arguing that clinics should be required to report details about their use
of preimplantation genetic diagnosis, a procedure used to screen embryos for certain genetic
conditions before implantation through in vitro fertilization). Preimplantation genetic diagnosis was
originally "used to prevent the birth of children with deadly genetic disorders, but it is now used for
more controversial reasons, such as to select for sex." Id. at 846.
19. See Ellen S. Fischer, Note, The 'Wild West' of Medicine: An Argument for Adopting the
United Kingdom's 'HFEA' Framework to Improve the Market for Assisted Reproduction in the

United States, 39 Nw. J. INT'L L. & BUS. 201, 204-05, 210 (2019) (arguing that the United States
should adopt a scheme over the assisted reproduction market that is similar to that of the United
Kingdom's Human Fertilisation and Embryology Act, which allows for a streamlined and
authoritative approach with one governing body to license, oversee, and promulgate regulations in
the IVF industry).
20. See infra Part II.
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federal regulation governing the fertility industry. 2' An examination and
comparison of the states' regulatory framework, along with an overview
of the current fertility-related federal legislation, will also be included in
Part 11.22 Part III will then call attention to the lack of uniform regulation
surrounding misimplantations and provide examples of misimplantations
that have occurred as of late. 23 Offering a solution, Part IV of this Note
will propose that the current federal statute, the Fertility Clinic Success
-Rate and Certification Act ("FCSRCA"), be modified to require fertility
clinics to report statistics regarding their error rates, specifically errors
concerning instances of misimplantation. 24 This Note will argue that this
solution is best suited to be implemented at a federal level, rather than on
a state-by-state basis.25 This Note takes this position because federal
oversight will yield greater transparency in a shorter amount of time,
promote uniformity, and decrease consumer confusion when prospective
parents research and select an ART clinic. 26
II. BABY STEPS: A WALK THROUGH ASSISTED REPRODUCTIVE
TECHNOLOGY, INCLUDING IVF AND ITS RELATED LEGISLATION

Before examining the more compelling issues surrounding
misimplantation of embryos into an unintended woman and legal issues
inherent in such practices, 27 a basic review of the methods and
technologies used in assisted reproduction is necessary. 28 Several notable
public figures have taken advantage of varying reproductive
technologies as of late, 29 increasing the discussion and coverage
30
surrounding the technology relied upon in the fertility sphere. In
response to the increased use of reproductive technologies, federal and
state legislation has been enacted with varying severity of regulation and
enforcement.31 With this foundational knowledge, the reader can better
appreciate the legislative solution proposed in this Note, which aims to

21. David Adamson, Regulation of Assisted Reproductive Technologies in the United States,
39 FAM. L.Q. 727, 728-29, 731 (2005) (arguing that regulation of the fertility field in the United
States is fragmented but has become more unified in recent years).
22. See infra Part II.D-E.
23. See infra Part III.
24. See infra Part IV.
25. See infra Part IV.B-D.
26. See infra Part IV.
27. See infra Part III.
28. See infra PartI.A.
29. See infra Part H.B.
30. See infra text accompanying notes 55-59.
31. See infra Part II.D-E.
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better assist hopeful parents in choosing a competent fertility clinic
provider. 32
A.

Learn to CrawlBefore You Walk: Defining Assisted Reproductive
Technology

ART generally includes "all fertility treatments in which both eggs
and embryos are handled outside of the body." 33 ART treatments involve
"removing mature eggs from a woman's ovaries using a needle,
combining the eggs with sperm in the laboratory, and returning the
embryos to the woman's body or donating them to another woman.""
ART can involve the use of eggs from a woman who does not give birth
to the resulting child.35 ART methods are inclusive of other treatments
beyond IVF, such as "zygote intrafallopian transfer, gamete
intrafallopian transfer, and intracytoplasmic sperm injection," among
others. 36 INF, the most common and effective form of ART procedures,
now assists in "1 to 2 percent of all U.S. births annually."37
IVF is a medical procedure that involves "administration of fertility
drugs to the woman, surgical extraction of her eggs, fertilization in a
laboratory, and surgical implantation of the resulting embryos into the
woman's womb."3 8 In some IVF procedures, fertilization involves a
special technique known as intracytoplasmic sperm injection, where a
single sperm is injected directly into a woman's egg. 39 Just one IVF

32. See infra Part IV.
33. Reproductive Health: Infertility FAQs, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/reproductivehealth/Infertility/index.htm (Jan. 16, 2019). Commentators have
acknowledged that there is no single definition of the term "embryo," but in this Note, "embryo"

will refer to "a human egg fertilized in vitro (outside the body) by human sperm, whose cell division
is allowed to develop only up to a defined and limited period of time after fertilization." Susan L.
Crockin, The "Embryo" Wars: At the Epicenter of Science, Law, Religion, and Politics, 39 FAM.

L.Q. 599, 601 (2005).
34. Reproductive Health: Infertility FAQs, supra note 33.
35. Id.
36. Kitty L. Cone, Note, Family Law-Egg Donation and Stem Cell Research-Eggsfor Sale:
The Scrambled State of Legislation in the Human Egg Market, 35 U. ARK. LITTLE ROCK L. REV.
189, 194 (2012). Gamete intrafallopian transfer involves "using a fiber optic instrument called a
laparoscope to guide the transfer of unfertilized eggs and sperm (gametes) into a woman's fallopian
tubes through small incisions in her abdomen." CTRS. FOR DISEASE CONTROL & PREVENTION,

supra note 13, at 3. Zygote intrafallopian transfer involves "fertilizing a woman's eggs in the
laboratory and then using a laparoscope to guide the transfer of the fertilized eggs (zygotes) into a
woman's fallopian tubes." Id.
37.

Reproductive Health: Infertility FAQs, supra note 33; IVF by the Numbers, supranote 11.

38. Hall v. Nalco Co., 534 F.3d 644, 645 (7th Cir. 2008). In considering the issue and solution
proposed by this Note, it is important to be cognizant of the fact that "infertility affects both men
and women." Id.
39. Reproductive Health: Infertility FAQs, supra note 33.
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treatment can take "weeks to complete, and multiple treatments are
40
sometimes needed to achieve a successful pregnancy." The national
average cost of one IVF cycle is around $12,000, which does not include
subsequent medications that can run up costs ranging from $3,000 to

$5,000.41
B.

Notable Instances ofART Usage

Sir Robert Edwards, a British embryologist, and Dr. Patrick
Steptoe, a British gynecologist, 42 are responsible for the first successful
instance of IVF in the world. 43 Dr. Steptoe had knowledge and
experience in extracting eggs, while Sir Edwards was well-versed in
fertilizing such eggs.44 Their collective, successful efforts in retrieving
both an egg from the eventual birth mother and sperm from her husband
enabled the duo to mix the egg and sperm in a petri dish and implant the
embryo in the mother's womb. 45 Their monumental work resulted in the
1978 birth of Louise Brown. 46 Sir Edwards was later "awarded the
Nobel Prize in Physiology or Medicine 'for the development of in vitro
fertilization.' "7 The first infant conceived with the aid of ART in the
United States followed shortly thereafter in 1981.48 That year, after
forty-one failed attempts at INF, a Massachusetts-based couple finally
gave birth to a baby that was genetically theirs.49
Notable celebrities have also taken advantage of ART options
available to them.50 Mariah Carey was able to give birth at the age of
forty-one after receiving donor eggs that were successfully implanted in

&

40. Hall, 534 F.3d at 645-46.
41. Jennifer Gerson Uffalussy, The Cost of IVF: 4 Things I Learned While Battling Infertility,
FORBES (Feb. 6, 2014, 3:00 PM), https://www.forbes.com/sites/learnvest/2014/02/06/the-cost-of(expanding upon the financial
ivf-4-things-i-learned-while-battling-infertility/#18ddlfa424dd
details of IVF). Because "few healthcare plans cover fertility treatments, IVF costs are primarily
paid out-of-pocket, often making it 'too expensive for more than a single try,' increasing pressure
on the physician or clinic to achieve a successful result." See Cone, supra note 36, at 202-03.
42. Andrew Danielson, Patrick Christopher Steptoe (1913-1988), EMBRYO PROJECT ENCYC.
(June 10, 2009), https://embryo.asu.edu/pages/patrick-christopher-steptoe-1913-1988.
43. Sinem Karipcin, We've Come a Long Way, Baby: The History of IVF, U.S. NEWS
wORLD REP. (July 26, 2018), https://health.usnews.com/health-care/for-better/articles/2018-07(examining the successes associated with IVF
26/weve-come-a-long-way-baby-the-history-of-ivf
since the first successful "test tube baby" was born over forty years ago).
44. Danielson, supra note 42.
45. Karipcin, supra note 43.
46. Danielson, supra note 42.
47. Karipcin, supra note 43.
48. Cone, supra note 36, at 201.
49. Karipcin, supra note 43.
50. Id.
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her.5 ' Jimmy Fallon and Neil Patrick Harris both became fathers through
the hiring of surrogates.5 2 Chrissy Teigen and John Legend conceived
two children utilizing IVF.53 Teigen has been forthcoming in discussing
her ART and IVF experiences, sharing with her Instagram followers that
"people are just curious and I think hearing success stories gives people
hope. I'm all for talking about IVF.""
As IVF becomes more mainstream through press coverage and
celebrity influence, the accessibility of IVF knowledge to those without
a public following has grown as well.55 Clinics have attempted to
respond to the consumers' twofold interest in the process: having a baby
coupled with the financial concerns associated with ART procedures.5 6
One option available through some IVF providers is a "money-back
guarantee[]," where the patient pays a premium for a guarantee of
successful pregnancy and birth, rather than paying per cycle. 57 Some
clinics also offer financing for their patients' treatments with loans,
graduated repayments, or outcome-based pricing models. 58 Nonetheless,
costs associated with ART treatments, including IVF, continue to be a
persisting issue. 59
51. Id.
52. Id.
53. Elise Sol6, Chrissy Teigen Shares Adorable Photo of Baby Miles, IVF Journey, HUFFPOST
(July 2, 2018), https://www.huffpost.com/entry/chrissy-teigen-shares-photo-of-baby-miles-ivfjourney-hearing-success-stories-gives-people-hope_n_5b33a4b2e4bb5e692f3647d.
54. Id. Teigen has also been open with the media in sharing that her first attempt at IVF was
unsuccessful, and that the experience was "devastating" for her and her family. Korin Miller,

Chrissy Teigen Says It Was 'Devastating'When Her First IVF Round Didn't Work, SELF (Apr. 5,
2018), https://www.self.com/story/chrissy-teigen-first-ivf-round-didnt-work.
55. See supra notes 50-54 and accompanying text. See generally IVF Explained
(@ivf explained), INSTAGRAM, http://instagram.com/ivf explained?igshid=elqjudoo769c (last
visited Feb. 8, 2021) (explaining to its followers the concepts, science, and methods behind IVF);
see

also

Modem

Fertility

(@modernfertility),

INSTAGRAM,

http://instagram.com/

modernfertility?igshid=6p3m5hzrusn (last visited Feb. 8, 2021) (providing insight into fertility with
digital tools including hormone, ovulation, and pregnancy tests).
56.

See Megan Leonhardt, Women Are Traveling Far and Wide for Affordable IVF-Here's

Why
It's So
Expensive, CNBC:
MAKE
IT (Aug.
13,
2019, 3:09
PM),
https://www.cnbc.com/2019/08/13/women-are-traveling-far-and-wide-for-affordable-ivf.html
(explaining that most insurance policies do not cover the costs of IVF, so clinics attempt to offer
pricing packages to offset the costs and risks). In fact, only sixteen states, including California and
New York, currently "require insurance companies to have some sort of coverage" for insureds

seeking fertility treatments. Id.
57. Id. ("Patients pay more for the guarantee than they otherwise would if they were
successful after just one IVF cycle."). A "cycle" is typically known as a multi-step treatment that
can take multiple weeks "rather than a procedure at a single point in time." CTRS. FOR DISEASE
CONTROL & PREVENTION, supra note 13, at 4.

58. Katie Young & Jessica Dickler, Infertility Treatment Is Burying Families in Debt as They
Choose to Have Children Later in Life, CNBC (Apr. 28, 2019, 9:35 AM),
https://www.cnbc.com/2019/04/26/infertility-treatment-is-putting-families-in-debt.html.
59. See id. (spotlighting one couple who has taken on more than $24,000 in debt over one

Published by Scholarly Commons at Hofstra Law, 2021

7

Hofstra Law Review, Vol. 49, Iss. 2 [2021], Art. 7

HOFSTRA LAW REVIEW

542

C.

[Vol. 49:535

The Right to Procreate

The first iteration of international human rights as we know them
today was set forth in the Universal Declaration of Human Rights

("UDHR") in December of 1948.60 Since its drafting, the UDHR "has
been translated into over 500 languages." 61 Article 1 of the UDHR
begins by stating, "All human beings are born free and equal in dignity
and rights." 62 The UDHR also guarantees "the right to marry and to
found a family" under Article 16.63
Likewise, U.S. case law establishes the right to privacy and
personhood.64 This guarantee is expansive and includes the right of
individuals to procreate, regardless of marital status. 65 The tension
between parental and biological rights has even made its way to the
Supreme Court of the United States. 66 Though the existing case law
protects the right to procreate, scholars currently debate how the
parameters of such a right will evolve in the context of ART, including
IVF, paid surrogacy, and egg donation.6 7

year, paying out-of-pocket for fertility treatments); see also Leonhardt, supra note 56 (highlighting
another couple who could afford just one cycle of IVF treatment before going into debt).
60.

Lauren

B. Paulk, Embryonic Personhood: Implications for Assisted Reproductive

Technology in InternationalHuman Rights Law, 22 AM. U. J. GENDER, SOC. POL'Y & L. 781, 783,
796-97 (2014) (analyzing the "legal personification of embryos ... through the lens of human rights
treaties").
61. Universal

Declaration

of

Human

Rights,

UNITED

NATIONS,

https://www.un.org/en/universal-declaration-human-rights (last visited Feb. 8, 2021) ("[T]he
Declaration was proclaimed by the United Nations General Assembly .. .as a common standard of
achievements for all peoples and all nations.").
62. G.A. Res. 217 (III) A, Universal Declaration of Human Rights, art. 1 (Dec. 10, 1948).
63. Id. at art. 16.
64. See Planned Parenthood of Se. Pa. v. Casey, 505 U.S. 833, 851 (1992) (holding that "[o]ur
law affords constitutional protection to personal decisions relating to marriage, procreation,
contraception, family relationships, child rearing, and education"); Skinner v. Oklahoma, 316 U.S.
535, 541 (1942) (protecting the "basic civil rights of man," including marriage and procreation).
65. See Eisenstadt v. Baird, 405 U.S. 438, 453 (1972) ("If the right of privacy means
anything, it is the right of the individual, married or single, to be free from unwarranted
governmental intrusion into matters so fundamentally affecting a person as the decision whether to
bear or beget a child.").
66. See Michael H. v. Gerald D., 491 U.S. 110, 121, 124 (1989) (plurality opinion) (holding
that the biological father did not have a liberty interest traditionally protected by society that would
give rise to a substantive due process claim).
67. See supra notes 64-66 and accompanying text; see also Carl H. Coleman, Assisted
Reproductive Technologies and the Constitution, 30 FORDHAM URB. L.J. 57, 59-60, 62 (2002)
(discussing the basic questions society must confront when allocating greater social oversight of
ART); John A. Robertson, Assisting Reproduction, Choosing Genes, and the Scope of Reproductive
Freedom, 76 GEO. WASH. L. REv. 1490, 1497, 1503 (2008) ("[I]t is not a stretch to think that a
future Supreme Court majority would allow states to protect human life from fertilization onward,
whether the entity at stake is inside or outside the body.").
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Professor Coleman, Associate Professor and Associate Director of
the Health Law and Policy Program at Seton Hall Law School, argues
that the aforementioned parameters will be determined by how "the
principle of procreative liberty is interpreted by the Supreme Court" and
whether the Court decides that ART technologies are entitled to "special
constitutional protection." 68 Professor Rao, Associate Professor at the
University of California, Hastings College of Law, argues that the
"discrete acts involved in procreation," including those involved with
assisted reproduction, are protected by "the rights of privacy, bodily
autonomy, and equal protection work[ing] together."69 In making this
argument, Professor Rao suggests that the right to enter the reproductive
commerce market is not automaticallyconstitutionally protected because
the "activities do not implicate private relationships," and instead, the
right only attaches when procreation occurs "within the confines of a
close personal association."" On the other hand, John Robertson,
Vinson and Elkins Chair in Law at the University of Texas School of
Law, argues that the principle of procreative liberty protects the
71
individual's freedom to have a child biologically related to the parent.
Ann Massie, Associate Professor at the Washington and Lee University
School of Law, pushes back against Robertson's theory.72 Professor
Massie contends that ART techniques used to have children do not
implicate the same values that are protected by the privacy cases under
constitutional law, such as marital intimacy or integrity of the family
unit. 73
Views on the use and accessibility of ART procedures are now
being weighed in the confirmation process of federal judges in the
68. See Coleman, supra note 67, at 60. Professor Coleman acknowledges that forecasting the
constitutional analysis of this issue involves some degree of speculation: "Like all questions about
the scope of substantive due process protections, the concept of procreative liberty is susceptible to
multiple interpretations, depending on the level of generality at which the principle is defined." Id.
at 68.
69. Radhika Rao, Reconceiving Privacy: Relationships and Reproductive Technology, 45
UCLA L. REV. 1077, 1079-80 (1998).
70. Id. at 1079. Privacy is a "structural right that protects private relationships as a mechanism
to check excessive governmental power." Id. at 1104.

71. John A. Robertson, Two Models of Human Cloning, 27 HOFSTRA L. REV. 609, 618-19
(1999). Robertson makes this argument in the context of human cloning, where he argues that this
right should only be denied if substantial harm from having a child via cloning could be shown. Id.
72.

See Ann MacLean Massie, Regulating Choice: A Constitutional Law Response to

Professor John A. Robertson's Children of Choice, 52 WASH. & LEE L. REV. 135, 144 (1995).
Professor Massie urges that the issue with Robertson's approach "is that it ignores both the manner
in which constitutional interpretation comes about and the underlying reasons for the way in which
the Supreme Court approaches constitutional questions." Id.
73. Id. at 162 ("The clear message is that not all procreative behavior is subject to the
heightened protection of the constitutional right of privacy.").
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United States. 74 In 2019, the Senate weighed then nominee Sarah
Pitlyk's views regarding protection for frozen embryos and the right to
utilize fertility procedures or surrogacy when considering her
appointment to the United States District Court for the Eastern District
of Missouri. 75 Pitlyk has written that "surrogacy 'is harmful to mothers
and children,"' and has also argued that frozen embryos should be
protected under the law as human beings. 76 Despite the controversy
surrounding then President Trump's decision to nominate Pitlyk for the
lifetime position, including Pitlyk's unanimous rating as "Not Qualified"
by the American Bar Association, the Republican-controlled Senate
confirmed Pitlyk to the judiciary by a 49-44 vote.77
D. FederalRegulation of ART
In response to the increased usage of ART, Congress enacted the
FCSRCA in 1992.78 This law is sometimes referred to as "the Wyden
Law." 79 The FCSRCA requires clinics that utilize ART methods to
annually report their success rates to the CDC. 80 The CDC then
consolidates, organizes, and publishes this information in a report that
the general population can access. 81 The report is organized
alphabetically by state. 82 Included within the report is an appendix that
lists the current names and addresses of all reporting clinics, along with

74. See Mark Joseph Stem, Senate Confirms Trump JudicialNominee Who Fought Against
3:02
2019,
4,
(Dec.
SLATE
and Fertility Treatment,
Surrogacy,
Abortion,

PM), https://slate.com/news-and-politics/2019/12/sarah-pitlyk-trump-judge-ivf-abortion.html.
75. Id.
76. Id. Pitlyk has also opined that destroying frozen embryos equated to "children" being
"killed." Id.
77. Id.
78. Adamson, supra note 21, at 731; Fertility Clinic Success Rate and Certification Act of
1992, Pub. L. No. 102-493, 106 Stat. 3146 (codified as amended at 42 U.S.C. §§ 263a-1-a-7).
79. Adamson, supra note 21, at 731. Then Congressman Wyden felt that a reporting system
would be valuable to hopeful parents when choosing between different Assisted Reproductive
Technology ("ART") providers. Id.
80. Ima E. Nsien, Navigating the Federal Regulatory Structure of Assisted Reproduction
Technology Clinics, A.B.A. (Nov. 1, 2017), https://www.americanbar.org/groups/healthlaw/

publications/aba_health_esource/2016-2017/nove mber2017/reproduction (reviewing the history
and status of regulation of reproductive technology in the United States and suggesting a more
comprehensive regulatory model).
81. CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 1. The latest report was
published in 2019 but is based on data from 2017 because the earliest possible date for clinics to
report complete annual data is nine months after the end of the reporting year, as all births from the
year in question have then occurred. Id. at 4. Data is then sent to, prepared by, and verified by the
CDC, resulting in a delay of publication. Id.
82. See generally id. at 25-522 (starting with clinics located in Alabama and ending with
clinics located in Wisconsin).
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a list of clinics known to be in operation in 2017 that did not report their
data to the CDC as required by law.83
Although the FCSRCA requires the CDC to develop and distribute
a model certification program for laboratory standards, states are not
statutorily required to adopt this model certification program.8 4 In fact,
the FCSRCA specifically states that there cannot be any "regulation,
standard, or requirement" established that would have "the effect of
exercising supervision or control over the practice of medicine in
assisted reproductive technology programs."" The most recently
published report notes that the CDC does not oversee nonfederal clinic
accreditation programs. 86 Instead, clinics can be accredited "by one of
the three nonfederal laboratory accreditation [p]rograms." 87 Under the
FCSRCA, the only definitive federal repercussion for accredited clinics
that do not report their success rates is a notation in the CDC's published
report.88
In response to the passage of the FCSRCA, the Department of
Health and Human Services ("DHHS") released a notice that "sets forth
the model certification program requirements." 89 Within this notice, the
CDC has pledged to distribute the model program to relevant state
officials outlined in the FCSRCA and will encourage such officials to

&

83. Id. app. C. The "clinics listed below provided ART services and were in operation as of
January 1, 2017 and accordingly were required to submit ART cycle data under the provisions of
the Fertility Clinic Success Rate and Certification Act passed by the US Congress." Id. app. C at
575.
84. 42 U.S.C. § 263a-2(b). What the Fertility Clinic Success Rate and Certification Act
("FCSRCA") "lacks, however, is any mechanism for prodding clinics to share their information
directly with patients and, more importantly, any means of penalizing those clinics that do not
report." Debora Spar & Anna M. Harrington, Building a Better Baby Business, 10 MINN. J.L. SCI.
TECH. 41, 63 (2009).
85. § 263a-2(i)(1).
86. CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 20. The accreditation

&

standards will vary depending on the organization, but may include "components for personnel,
quality control and quality assurance, specimen tracking, results reporting, or the performance of
technical procedures." Id. at 21.
87. Assisted Reproductive Technology (ART): Policy Documents, CTRS. FOR DISEASE
CONTROL & PREVENTION, https://www.cdc.gov/art/nass/policy.html (Feb. 8, 2017).
88. See Damiano, supra note 18, app. C at 851. But see CTRS. FOR DISEASE CONTROL
PREVENTION, supra note 13, at 575 (calling for "consumers who are aware of a clinic . . in
operation ... but ... not included in [the] report's lists of either reporting or nonreporting clinics"

to contact the CDC with the name, address, and telephone number of the nonreporting clinic, in
order for it to be included in future reports).
89. Implementation of the Fertility Clinic Success Rate and Certification Act of 1992-A
Model Program for the Certification of Embryo Laboratories, 64 Fed. Reg. 39,374, 39,374 (July 21,
1999). This notice also incorporates comments that the CDC received from professional
organizations, a consumer advocacy group, a manufacturer, and "individuals employed in embryo

laboratories or ... clinics[]." Id. at 39,375. Responses to each comment are included in the notice as
well. Id. at 39,376-82.
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90
However, the CDC
have their state adopt the model program.
cautioned that "the model certification program for embryo laboratories
does not provide for a [f]ederal oversight role." One provision of the
model certification program requires a quality management program
both "to assure the quality of... services provided and to identify
failures ... as they occur." 92 Nonetheless, the model program does not
impose a mandate to disclose these instances of misimplantation to the
93
CDC or to the public at large.

E.

State Regulation of ART

Each state can decide to enforce the FCSRCA penalties-or notunder the police powers ensured to the states via the Tenth
Amendment. 94 The FCSRCA respects the states' regulatory and
enforcement jurisdiction by leaving the penalties for noncompliance to
95
The legislation stipulates that the
be decided by the states.
the [s]tate or by accreditation
"by
issued
be
will
certifications
96
organizations." Suspensions or revocations of such accreditation may
be based on a "state or organizations[']" finding that the owner,
operator, or employee of the laboratory "failed to comply with any
97
standards . .. applicable to the certification."
States also have exclusive jurisdiction to regulate insurance
coverage of fertility treatments, which has produced a variety of
98
coverage relating to ART procedures throughout the country. As of
November 2019, only nine states required IVF to be covered by insurers
in some form, but even in these states, the requirements to receive even
90. Id. at 39,382. The model program calls for personnel qualifications and responsibilities
and quality management, among other requirements. Id. at 39,386, 39,388. The model program also
requires specific hours of documented training for laboratory directors, supervisors, or reproductive
biologists in such clinics. Id. at 39,379.
91. Id. at 39,382.
92. Id. at 39,386. The model program also requires that "necessary corrective actions are
taken, documented and reviewed for effectiveness whenever failures in quality are identified." Id.
The laboratory must also retain records of the policies and procedures implemented for ten years, or
the length of time set forth by federal, state, or local law, whichever is later. Id. at 39,391.
93. See generally id. at 39,374-75 (setting forth the model certification requirements, which
do not include a duty to disclose such errors).
94. Nsien, supra note 80.
95. Id. ("[T]here is no enforcement mechanism provided for in the [FCSCRA] so it is unclear
how the CDC ensures that all ART programs remain in compliance.").
96. 42 U.S.C. § 263a-2(f)-(g)(1).
97. Id. § 263a-4(a).
98.

Alison Motluk, A State-by-State Guide to Where Your FertilityIs Covered-and Where It

Isn't, N.Y. TIMEs MAG., Nov. 10, 2019, at 5 (comparing, in detail, the coverage requirements of
seventeen different states and the coverage requirements, on a general level, of the United States as
a whole).
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the minimal coverage due can be burdensome. 99 The vast majority of
states either have no mandate to cover fertility treatments, including
IVF, or alternatively, mandate that insurance providers cover or offer
fertility treatment, but not necessarily IVF.100
1. New York: A Highly Regulated ART State
New York has used its state police powers to regulate medicine
very stringently, specifically prohibiting any "person or other entity
[from] . . . request[ing], accept[ing], receiv[ing], pay[ing] or giv[ing] any
fee[s]" to, or compensating "in connection with any surrogate parenting
contract," with limited exceptions. 101 These exceptions include payments
made "in connection with the adoption of a child" or payments "for
reasonable and actual medical fees and hospital expenses for artificial
insemination or in vitro fertilization services incurred by the mother in
connection with the birth of the child."' 02 Under New York law, a
"person or entity who ... arranges or .. . assists in the formation of a
surrogate parenting contract for a fee ... [is] subject to a civil penalty
not to exceed ten thousand dollars and forfeiture to the [S]tate of any
such fee" for the first offense, and is subject to a felony conviction for a
second offense. 103 A bill legalizing the practice of paid surrogacy is
currently backed by the Governor of New York, Andrew Cuomo. 104 The
efforts to overturn the ban on paid surrogacy recognize that
"reproductive technology has completely changed" as commercial
surrogacy increases in popularity across America.' 0 5 New York is
currently one ofjust three states that ban paid surrogacy contracts. 106
99. Id. (discussing New York's requirement that hopeful parents must wait a year without
conceiving before gaining coverage, unless the woman is thirty-five or older, in which case she
must wait six months, along with the limitations of Illinois' coverage, including an insurance
allowance for just four completed egg retrievals, and then two more toward another child in the
event of a live birth).
100. See generally id. (displaying a visual representation of state-by-state fertility coverage, or
lack thereof, with a map).
101. N.Y. DOM. REL. LAW § 123 (McKinney 2020).
102. Id. § 123(1)(a)-(b).
103. Id. § 123(2)(b).
104. Elizabeth Chuck, The Long Wait for Legalized Surrogacy May Soon End in New York,
NBC NEWS (Feb. 7, 2019, 4:25 AM), https://www.nbcnews.com/news/us-news/long-wait-legalizedsurrogacy-may-soon-end-new-york-n968541 (discussing a New York couple who missed the early
birth of their children after being forced to hire an out-of-state surrogate due to New York's ban on
surrogacy for hire).

105. Id.
106. Id. A surrogacy contract is designed to protect the intended parents, the surrogate mother,
and

the

baby.

Intended Parents: Understanding Surrogacy Contracts, SURROGATE.COM,

https://surrogate.com/intended-parents/surrogacy-laws-and-legal-information/understanding-surroga
cy-contracts (last visited Feb. 8, 2021). Fee contracts for surrogacy usually outline the base payment
to be made to the surrogate mother, along with fees should more than one child be born; additional
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New York has a history of exercising its regulatory jurisdiction in
ART-specific contexts. 107 In 1985,108 New York created a "State Task
Force on Life and the Law," which is responsible for developing
109
New York's
recommendations and policy in the ART industry.
Commissioner of Health is the chairman of the Task Force, and its other
members are comprised of "Governor-appointed volunteer experts" of
11 0
The
varying fields, including "law, medicine, nursing, and bioethics."
task force created a list of factors it considered important to the
"protection of procreative freedom," which are:
Bodily integrity, [m]arital intimacy, [t]he relationship between coital
reproduction and sexual intimacy, [t]he importance of being a parent
and raising a child, [t]he importance of carrying on a genetic line, [t]he
religious dimensions of decisions about procreation and child rearing,
[t]he woman's interest in carrying a fetus and giving birth, [t]he
intrusiveness of attempts to enforce laws limiting decisions about
procreation, [and t]he danger that placing control of reproduction in the
1
hands of the [S]tate will lead to eugenic policies.I

The working group concluded "the constitutional protection afforded
[to] particular forms of [ART] should be based on the degree to which
2
the procedure at issue implicates" the above-listed factors.
Commentators have noted that under such an approach, ART methods
involving a married couple using their own sperm and egg may be
afforded greater protections than an unmarried person using trait

selection technologies.

3

payment, should a caesarian section be warranted; lost wages due to the birth of the child; and
provisions regarding health insurance costs and coverage. See generally Surrogate Mother Costs,
WEST COAST SURROGACY INC., https://www.westcoastsurrogacy.com/surrogate-program-forintended-parents/surrogate-mother-cost (last visited Feb. 8, 2021) (outlining the 2020 schedule of
fees and costs at a California surrogacy center).
107. Yaniv Heled, The Regulation of Genetic Aspects of Donated Reproductive Tissue-The
Needfor FederalRegulation, 11 COLUM. SCI. & TECH. L. REv. 243, 255, 257-58 (2010).
108. About the Task Force on Life and the Law, N.Y. STATE DEP'T OF HEALTH,
https://www.health.ny.gov/regulations/task_force/about.htm (last visited Feb. 8, 2021).
109. Id.; Coleman, supra note 67, at 64. As part of its ART project, the "Task Force convened a
special working group to consider the constitutional issues surrounding the use of ARTs." Coleman,
supra note 67, at 64.
110.

About the Task Force on Life and the Law, supra note 108.

111.
112.
113.

Coleman, supranote 67, at 64-65.
Id. at 65.
Id. ("The Task Force specifically rejected the broad interpretation of procreative liberty

advocated by . .. commentators.").
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2. California: A Loosely Regulated ART State
California, on the other hand, has very limited regulation
surrounding gestational contracts.11 4 Parties to such a contract need only
stipulate the date the agreement was executed; the "persons from which
the gametes originated, unless donated gametes were used"; the "identity
of the intended parent or parents"; and a "disclosure of how the intended
parents will cover the medical expenses of the gestational carrier and of
the newborn or newborns."" 5 Parties to such an agreement "shall not
undergo an embryo transfer procedure ... until the . .. agreement for
gestational carriers has been fully executed.""1 6 An agreement executed
in accordance with this statute is "presumptively valid" and cannot "be
rescinded or revoked without a court order."'"' This lower standard of
protection surrounding ART procedures in California has been
criticized, as argued by newly-confirmed District Court Judge for the
Eastern District of Missouri, Sarah Pitlyk, in an amicus brief to the
Supreme Court: "[T]he practice of surrogacy has grave effects on
respect for motherhood and the unique
society, such as diminished
8
mother-child bond.""1
Because California loosely regulates gestational contracts, it has
developed into a worldwide destination for hopeful parents who seek
fertility treatment. 119 California's proximity to Silicon Valley and tourist
destinations offer hopeful parents the ability to leverage a clinic's access
to cutting-edge technology with the added benefit of making a vacation
out of their trip to the state.12 0 "[O]f the fifty busiest IVF clinics in the
United States," ten call California home.12 1 Part of this popularity may
be attributed to California's policy prohibiting discrimination against
people choosing to pursue IVF on the basis of "age, ancestry, color,
114.

See generally CAL. FAM. CODE

§ 7962

(West 2020) (outlining the elements that a

gestational agreement must contain).
115. Id. § 7962(a)(1)-(4).
116. Id. § 7962(d).
117. Id. § 7962(i).
118. See supra notes 74-76 and accompanying text; see also Motion and Brief of American
Association of Pro-Life Obstetricians & Gynecologists et al. as Amici Curiae in Support of
17-129),
(No.
239 (2017)
Ct.
138 S.
v. C.M.,
at 3, M.C.
Petitioner
https://www.thomasmoresociety.org/wp-content/uploads/2017/08/Amicus-Brief-in-M.C.-v.C.M..pdf.
119.
VOGUE

See Jancee Dunn, How California Became the World's Fertility Treatment Destination,
(Mar. 13, 2019), https://www.vogue.com/article/california-worlds-fertility-treatment-

destination (discussing the relationship between California's technology industry and the state's
burgeoning IVF industry).
120. Id. Dr. Boostanfar, a fertility doctor, fondly refers to the IVF process in California as a
"fertilization vacation," where patients come to receive fertility treatment, but stay for the sunsets

and beaches alike. Id.
121. See id.
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disability, domestic-partner status, gender, gender expression, gender
identity, genetic information, marital status, national origin, race,
religion, sex, or sexual orientation."122
The growing popularity of IVF in California can also be attributed
to the termination of China's one-child policy, which has caused the
fertility market demand in China to grow exponentially.123 By 2022, it is
anticipated that China's market for fertility services will more than
double the amount of money generated by the industry in 2016.124 Kyle
Francis, CEO of the Southern California Reproduction Center, partially
attributes the rise in "medical touris[ts]" from China to strong Chinese
cultural values that include extending the bloodline, along with growing
acceptance of treatment to address infertility.125
Despite the increase of IVF popularity in China, China's population
is still projected to decrease by approximately two percent by 2050.126
The projected decrease in population is likely due to a number of factors,
including "the cost of having children, housing availability and
nationwide economic stress-especially worrying given the rapidly
aging population."'2 7 In order to avoid long wait times, limited clinics,
and excess demand for fertility treatment, hopeful Chinese parents have
been taking their business abroad to other countries, including
Singapore, Thailand, South Korea, and the United States. 128
III. AN INCONCEIVABLE ISSUE: PERTINENT EXAMPLES OF
MISIMPLANTATION TODAY AND THE ABSENCE OF REGULATION
SURROUNDING THESE INSTANCES

In order to gain a functional understanding of the issue posed by the
current ART regulations, this Part will begin by providing examples of
hopeful parents who have been impacted by mistakes attributable to their

122. Motluk, supra note 98.
123. Chinese Women Are Driving a Global Fertility Industry Boom, BLOOMBERG (Sept. 17,
2018, 3:10 AM), https://www.bloomberg.com/news/articles/2018-09-16/chinese-women-aredriving-a-global-fertility-industry-boom.
124. Id.
125. Robert Blain, More Chinese Seek IVF Abroad, CHINADAILY.COM.CN (Feb. 21, 2018,
11:20 AM), http-/www.chinadaily.com.cn/a/201802/21/WS5a8ce57ca3lO6e7dccl3d3ld.html. Mr.
Francis also acknowledges the increasing number of late marriages due to career expansion for
women. Id.
126. Debbie Ponchner, A GlobalLook at Fertility,N.Y. TIMES MAG., Nov. 10, 2019, at 8.
127. Id.
128. Blain, supra note 125. Access to fertility clinics in other countries varies based on cultural
differences. See Jessica Grose, Access Is Everything: A Truth for All Ages, N.Y. TIMES MAG., Nov.
10, 2019, at 2. In France, lesbian and single mothers must seek fertility treatment in another country
in the European Union. Id.
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fertility clinic. 12 9 Next, this Note will examine an individual state's
autonomy in regulating medicine in the ART field. 0 An exploration of
self-regulation in this industry will follow.13 1 Finally, this Part will
conclude by offering a guided analysis of the federal regulation and
legislation surrounding ART.13 2
A.

Scrambled Eggs: Uncommon Mix- Ups that Commonly Appear in
the News Cycle

In April 1998, Deborah Perry-Rogers and her partner, Robert
1 33
Rogers, began an IVF treatment program at a New York-based clinic.
During the couple's IF treatment process, an embryo made of their
genetic material was "mistakenly implanted into the uterus of defendant
Donna Fasano, along with embryos from Ms. Fasano's and her
husband's genetic material."13 4 Ms. Fasano gave birth to two babies in
December of 1998, and genetic tests following the birth confirmed that
one of the babies was the Rogers' biological child.3 5 The Rogerses sued
the Fasanos, seeking a "declaratory judgement declaring the rights,
obligations and relationships of the parties concerning [the Rogers'
biological child]."1 36 The Rogerses also sued the clinic, "alleg[ing]
medical malpractice and breach of contract."'3 7
The Rogerses have not been the only family to experience the
unique heartache associated with a genetic child inadvertently being
born to incorrect parents. 138 "About a decade ago, [Mr. and Mrs.]
Manukyan ... [stored] their embryos" at CHA Fertility Center in Los
Angeles, California.1 39 In 2018, they returned to CHA Fertility Center to

129. See infra Part III.A.
130. See infra Part III.B.
131. See infra Part III.C.
132. See infra Part III.D.
133. Perry-Rogers v. Fasano, 715 N.Y.S.2d 19, 21 (App. Div. 2000).
134. Id. A troublesome legal dilemma has arisen with this technology: "When one woman's
fertilized eggs are implanted in another, which woman is the child's 'natural' mother?" Id. at 24.
135. Id. at 22.
136. Id.
137. Id.
138. See Isaac Stanley-Becker, She Gave Birth to Twins Through IVF. But the Babies Weren't
Hers,
a
Lawsuit
Alleges,
WASH.
POST
(July
8,
2019,
5:22
AM),
An anonymous couple
https://www.washingtonpost.com/nation/2019/07/08/twins-ivf-birth-lawsuit.
became suspicious that something had gone awry after the expecting mother's first sonogram
suggested she was carrying twin boys because she was previously informed that only one of the
couple's embryos was a boy and it was not even intended to be used in the IVF transfer in question.
Id.
139. Stanley-Becker & Brice-Saddler, supra note 8. The couple hails from Glendale,
California. Id.
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attempt an initial round of IVF with their previously-stored embryos. 4 0
Following multiple unsuccessful rounds of IVF, the Manukyans were
informed in the spring of 2019 that one of their embryos had actually
been implanted in the uterus of another woman in New York.14 1 The
Manukyans were not informed of this development until after the child
in question had already been born. 4 2 The lawsuit filed by the
Manukyans' attorney claimed that "[the Manukyans'] son had been
stolen from them when he was still an embryo and implanted into a
stranger that later became his birth mother." 4 3 After being informed of
the mix-up, the unidentified birth mother and her husband sued CHA
Fertility Center and the center's co-owners and directors, alleging
"medical malpractice, negligence, battery and intentional infliction of
emotional distress." 44 The Queens couple claimed to have "paid more
than $100,000 for facility fees, medication, laboratory expenses, travel
[expenses] and other costs" in an attempt to conceive a child that was
genetically theirs via IVF.45 The Manukyans also sued CHA Fertility
Center and filed a habeas corpus petition in order to gain custody of the
baby.1 46 Today, the Manukyans still do not know what became of the
other embryo that was intended to be used in their ART procedure. 4 7 "It
means that we live with the uncertainty that another embryo of ours may
be born to someone else," Mrs. Manukyan said. 148
Instances of embryo mix-ups have not been limited to hopeful
parents living in the United States.1 49 In 2015, a London-based couple
utilized the Connecticut-based CT Fertility P.C. clinic for IVF
140. Id.
141. Id.
142. Id.
143. Id.
144. Stanley-Becker, supra note 138.
145. Id.
146. Stanley-Becker & Brice-Saddler, supra note 8. Their petition was successful under the
theory that the surrogacy had been unintended, and the Manukyans were able to fly home to
California with their son eleven days after learning of the misimplantation. Id. Their attorney, Eric
wrubel, cited the sealed courtroom proceedings as among "'the most emotional scenes [he] ha[d]
seen in [his] 25 years' of practicing law." Id.
147. Id. Mrs. Manukyan has stated that she "will never be the same person anywhere again in
[her] life." Id. She further states that "CHA robbed [her] of [her] ability to carry [her] own child, to
be with him in the first couple moments of his life, to nurse him, to just do skin on skin contact. Just
be a mom to him." Eric Levenson & Cheri Mossburg, This Couple Got a Stranger's Embryo in an
IVF Mixup, and Someone Else Gave Birth to Their Baby, CNN (July 10, 2019, 7:07 PM),
https://www.cnn.com/2019/07/10/us/ivf-mixup-couple-lawsuit/index.html.
148. Levenson & Mossburg, supra note 147.
149. Daniel Tepfer, Couple Claims Trumbull Clinic Switched Their Embryos, CTPOST (Apr.
22, 2019, 4:09 PM), https://www.ctpost.com/local/article/Couple-claims-Trumbull-clinic-switchedtheir-13786141.php (explaining the lawsuit filed by the unnamed British couple against the fertility
center at which they stored their embryos).
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treatment.15 0 CT Fertility used the "husband's sperm and embryos from a
known donor."1 5 1 The couple gave birth to their first child in April of
2016.152 One year later, "the couple underwent a second IVF treatment at
CT Fertility with the [clinic] representing [that it was] using the embryo
from the known donor that was [allegedly] in storage at the clinic and
the husband's sperm." 153 According to the lawsuit, the treatments
undertaken by the couple cost approximately $200,000.154 The second
round of IVF was also successful in that it resulted in the couple giving
birth to a second child.15 5 However, "their second child appeared to have
a much darker skin pigmentation then [sic] either the father, the genetic
mother[,] or their first child[,] which was extremely unexpected and
perplexing as the children were supposed to have the same genetic
makeup." 156 A DNA test revealed that the two children were not
15
After receiving the news that their
genetically related to one another.7
children were unrelated, the couple developed an unwavering "fear" that
the embryo that was intended to be their second child had been
wrongfully transferred to another patient.15 8 CT Fertility has since
closed, 159 and the "couple ... seek[s] damages in excess of $15,000."160
Jury selection is scheduled to begin in 2021.161
B.

The State's Autonomy in Regulating Medicine

Neither the relatively deregulated state of California, nor the highly
regulated state of New York, has enacted legislation requiring clinics to

150. Id.
151. Id.
152. Id.
153. Id.
154. Rich Scinto, CT Fertility Clinic Mixed Up Embryos: Lawsuit, PATCH (Dec. 18, 2019,
11:53 AM), https://patch.com/connecticut/trumbull/ct-fertility-clinic-mixed-embryos-lawsuit.
155. Tepfer, supra note 149.
156. Id.
157. Id. A DNA test is used to determine the genetic material of a person's deoxyribonucleic
acids, which is unique to every person. DNA Science Explained, DNA DIAGNOSTICS CTR.,
https://dnacenter.com/the-science-explained (last visited Feb. 8, 2021) (discussing the "numerous
techniques" that have been developed "to learn more about how living things function and solve

genetic questions"). The DNA collected can be used for "relationship analysis," including that
relationship between siblings. Id. Commercial DNA testing kits have helped to expose a medical
ethical violation known as "fertility fraud," where fertility doctors lie to patients about the source of
the donor sperm. Adam Liptak, FightingFertilityFraud, N.Y. TIMES MAO., Nov. 10, 2019, at 9.
158. Tepfer, supra note 149 ("While the plaintiff's second son is loved in every aspect[,] the
plaintiffs live in constant, nagging, debilitating fear that the person whose genetic material was used
will realize, as they did, that the defendants negligently mixed up their genetic material.").
159. Id.
160. Scinto, supra note 154.
161. Id.
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report instances of implantation mix-ups, whether to the CDC or to the
State itself, for publication.16 2 As states are called on to "oversee medical
licensing, educational requirements and discipline for physician
misconduct," they have the legal power to revoke such a license. 163 The
states "have largely abdicated that responsibility when it comes to ART,
failing to implement safety standards or model programs for IVF
clinics."'6 Marcy Darnovsky, Executive Director for the Center for
Genetics and Society, points to the controversies that surround ART as
the reason for state lawmakers' hesitation in attempting to regulate the
industry. 165 Darnovsky specifically cites to the politically-charged topic
of abortion, "which touches on conception[,] ... embryos," and stem
cell research, in defending this position. 166
The CDC itself states that adopting the model certification program
is entirely voluntary, and has deferred approval and monitoring of
laboratory accreditation to the states.1 67 In the language that introduces
the FCSRCA's model certification program, the CDC recognizes the
state's autonomy in regulation, defining "State" as inclusive of
"expressly delegated powers to [a] political subdivision sufficient to
authorize the political subdivision to act for the State in enforcing
requirements equal to or more stringent than the model certification
program."1 68 The CDC implicitly acknowledges the states' autonomy in
this field by informing one commenter that if a state were to adopt its

162. See generally CAL. FAM. CODE § 7962 (West 2020) (including no such requirement);
N.Y. DoM. REL. LAW § 123 (McKinney 2020) (including no such requirement).
163. Kerry Breen, Lack of Oversight and RegulationsMay Lead to IVF Mishaps, TODAY (July
9, 2019, 3:24 PM), https://www.today.com/health/lack-oversight-regulations-may-lead-ivf-mishapst157872 ("There's no federal law, no state law, no enforced professional guideline that enforces
requirements, that licenses these facilities in the way that they label or diagnose or handle sperm,
eggs and embryos, that result in the creation of people.").
164. Fischer, supra note 19, at 212. An "ideal framework of ART regulation will be
independent, will take into account patients, providers, and the public, and will be free from
political, religious, or moral agendas." Id. at 222.
165. See Michael Ollove, States Not Eager to Regulate Fertility Industry, PEW: STATELINE
(Mar. 18, 2015), https://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2015/3/18/
states-not-eager-to-regulate-fertility-industry (discussing the Utah State legislature's decision to
provide children conceived via sperm donation access to their biological father's medical history,
and the general hesitancy of states to regulate the fertility industry).
166. Id. Darnovsky's opinion that legislatures are hesitant to regulate ART because of the ART
industry's surrounding controversial spheres is shared by other critics: "It is unregulated because it
touches on two, 'third-rail' issues .... It touches on abortion and also the creation of embryos,
which politicians run away from because too many people still disagree about the right to use
reproductive technologies, particularly who should pay for them and how much." Id.
167. Implementation of the Fertility Clinic Success Rate and Certification Act of 1992-A
Model Program for the Certification of Embryo Laboratories, 64 Fed. Reg. 39,374, 39,377 (July 21,
1999).
168. Id. at 39,383.

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss2/7

20

Chichi: In Vitro Fertilization, Fertility Frustrations, and the Lack of R

2021]

IN VITRO FERTILIZATION, FERTLITY FRUSTRATIONS

555

model program, it would be left to that state to determine fees associated
with certification. 169 The federal government has covered costs for
implementing the FCSRCA, including the development of the model
certification program and the publication of the annual report.17 0
C.

Self-Regulation

Two prominent professional organizations in the medical field
"develop and practice ethical guidelines and programs for laboratory
accreditation." 17 1 These groups are the American Society for
Reproductive Medicine ("ASRM") and the Society for Assisted
Reproductive Technology ("SART").1 72 SART is an affiliated society of
ASRM,17 3 and is "an organization of ART providers . .. [that] has been
collecting data and publishing annual reports . . . for fertility clinics in
the United States and Canada since 1989."174 The CDC contracted with
SART to use its "clinic specific database" in order to collect pregnancy
data from clinics.1'7 5 Before the enactment of the FCSRCA, SART's
registry system was voluntary. 17 6 However, after the legislation was
passed, it became mandatory for clinics performing ART procedures to
submit their data to SART, who then forwards it to the CDC for
compilation and publication.1 77 SART member clinics "perform more
than 95% of the [ART] cycles in the United States."' 78 ASRM and
SART publish guidelines covering "specific ART practice issues, such
as the number of embryos to be transferred in an ART procedure."1 79 A

169. Id. at 39,377.
170. Id. at 39,377-78.
171. Breen, supra note 163.
172. Id.
173. Latest Data from SART Show Increasing Use of Cryopreservation for Fertility
Preservation, SOC'Y FOR ASSISTED REPROD. TECH. (Apr. 5, 2019), https://www.sart.org/news-and-

publications/news-and-research/press-releases-and-bulletins/latest-data-from-sart-show-increasingThe Society for Assisted Reproductive
use-of-cryopreservation-for-fertility-preservation.
Technology ("SART") assisted then Congressman Wyden in developing the FCSRCA
requirements. Adamson, supranote 21, at 732.
174.

CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 1.

175. Reporting of Pregnancy Success Rates from Assisted Reproductive Technology
Programs, 65 Fed. Reg. 53,310, 53,312(Sept. 1, 2000).
176. Id.
177. Id.
178. Latest Data from SART Show Increasing Use of Cryopreservation for Fertility
Preservation, supra note 173.
179. CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 7. The year-by-year

SART's National Summary Report gives "patients, professionals and the public the big picture view
of the improvements and advances that have occurred in ART over the decades." Latest Datafrom
SART Show Increasing Use of Cryopreservationfor Fertility Preservation, supra note 173. Both the

American Society for Reproductive Medicine ("ASRM") and SART have worked in collaboration
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published ethics committee opinion by ASRM recommends guidelines
to avoid mishandling embryos and includes suggestions such as
self-implementing written procedures to prevent such an error in the first
instance. 180 ASRM implores physicians to implement "rigorous
procedures" in doing so.181 ASRM has attempted to guide such "rigorous
procedures" by stipulating:
To prepare for the possibility that errors may occur despite these
procedures, programs should foster an environment of truth telling that
will allow prompt identification and disclosure of errors to patients. It
is recommended that clinics have written policies and procedures that
182
outline how to reduce and disclose medical errors.

Sean Tipton, chief lobbyist for ASRM, challenges the view that
reproductive medicine is unregulated, asserting that the field is "one of
18 3
the most heavily regulated fields of medicine in the [United States]."
In support of this position, Tipton points to federal regulation of drugs
and medical devices as evidence of components of ART that are
regulated by the federal government. 184 It is true that ASRM issues
guidelines to encourage self-regulation. 185 However, no sanction arises
when practitioners or clinics violate the guidelines.186 Arthur Caplan,
Director of the Division of Medical Ethics at New York University's
School of Medicine, asserts that the field will continue to be lightly
regulated because it has evolved as a business, rather than a "research
with Caplan's
agree
industry experts
Some
enterprise."'87

with the CDC to report success rates in the annual FCSRCA report. National ART Surveillance,
CTRS. FOR DISEASE CONTROL & PREVENTION, https://www.cdc.gov/art/nass/index.html (Jan. 27,

2021).
180. Am. Soc'y for Reprod. Med., Disclosure of Medical Errors Involving Gametes and
Embryos: An Ethics Committee Opinion, 106 FERTILITY &

STERILITY

59, 62 (2016). When errors

are "clinically relevant, fairness to patients, protection from harm, and respect for patient autonomy
require open and honest disclosure of errors immediately upon recognition, even though disclosure
may be difficult for clinicians." Id. at 59-60.
181. Id. at 59.
182. Id. at 62.
183. Michael Ollove, Lightly Regulated In Vitro Fertilization Yields Thousands of Babies
Annually, WASH. POST (Apr. 13, 2015), https://www.washingtonpost.com/national/healthscience/lightly-regulated-in-vitro-fertilization-yields-thousands-of-babies-annually/2015/04/13/fl f3f
a36-d8a2-11 e4-8103-fa84725dbf9d_story.html.
184. Id.
185. See Am. Soc'y for Reprod. Med., supra note 180, at 59 (outlining suggestions to prevent
and disclose errors related to handling embryos). But see Ollove, supra note 183 (discussing critics'
argument that ASRM works to "advance the business interests of its members, [unrestrained] by
government regulation").

186. Ollove, supra note 183.
187. Id. The lack of regulation surrounding ART is cited as a benefit in some instances, such as
those that involve same-sex couples or single parents as they avoid facing "built-in barriers" in
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characterization, pointing to congressional hesitation to regulate on an
issue that implicates abortion.188 The current scheme has been criticized,
as practitioners are relied on to comply with self-adopted standards and
self-reporting guidelines while still participating in an economically
competitive market that disincentivizes voluntary disclosure. 189
D.

The Absence of FederalRegulation

The Secretary of the DHHS is required to publish the names of
laboratories that have not complied with FCSRCA's reporting
standards.190 Though this may sound like a compelling deterrent,
laboratories that do not comply with reporting requirements are not
subject to any sanctions imposed by the CDC.1 91 If and when a state
chooses to adopt the model certification program set forth by the
FCSRCA, its laboratories become subject to inspection by the state or
DHHS Secretary. 19 2 So far, no states have required their laboratories to
opt into the model program.193 In the published 2017 ART Fertility
Clinic Success Rates Report, each non-reporting clinic had an entire
page dedicated to it.' 94 In this report, there were fifty clinics that did not
report their yearly data.195 The clinic's name and city are listed on an
individual page devoted to each non-reporting clinic, 196 along with the
following provision:
This clinic provided ART services during 2017 and is therefore
required to submit ART cycle data under the provisions of the Fertility
Clinic Success Rate and Certification Act. This clinic either did not
submit 2017 ART cycle data or the clinic's Medical Director did not
approve the clinic's 2017 ART cycle data for inclusion in this
report. 197

utilizing ART methods to conceive. Id. Same-sex couples have faced barriers in seeking out fertility
treatment centers in developed countries in the European Union. Grose, supra note 128, at 2.
188. Ollove, supra note 183.
189. Heled, supra note 107, at 277-78.
190. 42 U.S.C. § 263a-5.
191. Jaime King, Predicting Probability: Regulating the Future of Preimplantation Genetic
Screening, 8 YALE J. HEALTH POL'Y L. & ETHICS 283, 334 (2008).

192. § 263a-2(g)(1), (hXl).
193. King, supra note 191, at 330.
194. See, e.g., CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 63, 158
(revealing clinics in Glendale, California, and Lutz, Florida, that were required to report ART cycle
data under the FCSRCA but failed to do so).
195. Id. at 575-77.
196. See, e.g., id. at 158 (showing one non-reporting clinic's individualized entry in the report).
197. Id. The same provision is listed on other non-reporting clinics' individualized entries in
the report. See, e.g., id. at 159, 213, 237.
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An example of a non-reporting clinic found in the 2017 report is
Braverman Reproductive Immunology, PC, located in Woodbury, New
York. 198 Of the fifty non-reporting clinics noted in the 2017 report,
thirteen have closed since January 1, 2017.199
While the FCSRCA mandates that clinics report their success rates
to the CDC for annual publication, the FCSRCA fails to set forth
statistical reporting and publishing requirements governing the rate in
which the clinics err.2 1 Commentators have pointed to other notable
omissions in the reporting requirements set forth by the FCSRCA and
CDC. 2 01 Ima Nsien, an attorney working with the California-based ADLI
Law Group notes:
[T]here is no state regulation of the number of children that may be
conceived by an individual donor, no rules regarding the types of
medical information and updates that must be supplied by young
donors as they age, no standards regarding genetic testing on embryos,
no limits on the age of donors, and virtually no regulation of the
202
gametic material market.

Further, states have not elected to develop their certification
programs based on the model program outlined by the FCSRCA. 203
States that wish to provide patients with embryo misimplantation rates
can instead require disclosure under state law. 204 This piecemeal
approach has left gaps in the legislation surrounding the fertility
industry. 205 As "states have done very little to fill the void left by the
lack of federal legislation," most clinics have only a low-threshold duty
to comply with the federal reporting standard as imposed by the
FCSRCA requirements.206
198. Id. at 367. There are four New York-based clinics that are listed as having provided ART
services in 2017, and thus were required to submit ART cycle data under the FCSRCA, but instead
failed to report. Id. at 577.
199. Id. at 575-77.
200. Nsien, supra note 80 (noting that clinics must report birth rates and other factors, such as
demographic information, but not error rates).
201.

Lynn D. Wardle,

Global Perspective on Procreation and Parentage by Assisted

Reproduction, 35 CAP. U. L. REv. 413, 419 (2006) (pointing to criticism the FCSRCA has faced,
including the principal finding of the President's Council on Bioethics after its 2004 study of ART
regulation: "There is no uniform, comprehensive, enforceable system of data collection, monitoring,
or oversight for the biotechnologies affecting human reproduction."). But see Adamson, supra note
21, at 732 (stating that "the FCSRCA has been considered a success by physicians, patients and the
government").
202. Nsien, supra note 80.
203. Adamson, supra note 21, at 732.
204. See Ollove, supra note 165 ("[A]spects of ART are simply unaddressed by the states.").
205. See CHARLES P. KINDREGAN, JR. & MAUREEN MCBRIEN, ASSISTED REPRODUCTIVE
TECHNOLOGY: A LAWYER'S GUIDE TO EMERGING LAW AND SCIENCE 31-32 (2d ed. 2011).

206.

See Nsien, supra note 80.
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IV. BABY PROOFED: A STATISTIC INDICATING OCCURRENCES OF
MISIMPLANTATION SHOULD BE ADDED TO THE FCSRCA REPORTING
REQUIREMENTS

This Note's proposed solution is best explained by first examining
the legislation's current required reporting statistics. 207 Next, the offered
changes to the reporting requirements and statutory definitions will be
set forth. 208 This Part will also argue that the proposed changes to the
FCSRCA are an ideal solution because states will retain their
enforcement abilities guaranteed to them under the Tenth Amendment
and currently set forth in the existing FCSRCA legislation.209
Furthermore, potential patients, hopeful parents, and the general public
will continue to enjoy access to transparent information when
considering clinics in the United States, while benefiting from a
heightened standard of reporting requirements. 2 10 This Part will also
demonstrate that this proposed solution can be explored, questioned, and
considered by experts in the industry and the general public in a manner
consistent with the modifications to the FCSRCA that the CDC is
currently considering. 21
A.

The Legislation as It Currently Stands

The current FCSRCA legislation outlines the figures that clinics
must report to the CDC for publication in its annual report and
mandates:
(a) In general: Effective 2 years after October 24, 1992, each assisted
reproductive technology (as defined in section 263a-7 of this title)
program shall annually report to the Secretary through the Centers for
Disease Control(1) pregnancy success rates achieved by such program through each
assisted reproductive technology, and
(2) the identity of each embryo laboratory (as defined in section 263a-7
of this title) used by such program and whether the laboratory is
certified under section 263a-2 of this title or has applied for such
212
certification.

207.
208.
209.
210.
211.
212.

See infra Part W.A.
See infra Part IV.B.
See infra Part IV.C.
See infra Part IV.D.
See infra Part V.D.
42 U.S.C. § 263a-1(a).
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The FCSRCA, as currently compiled, continues on to define which
subfactors must be included in the live birth rate, including the age,
diagnosis, and other significant factors concerning the genetic parent:
(b) Pregnancy success rates
(1) In general: For purposes of subsection (a)(1), the Secretary shall, in
consultation with the organizations referenced in subsection (c), define
pregnancy success rates and shall make public any proposed definition
in such manner as to facilitate comment from any person (including
any Federal or other public agency) during its development.
(2) Definition: In developing the definition of pregnancy success rates,
the Secretary shall take into account the effect on success rates of age,
diagnosis, and other significant factors and shall include in such
rates(A) the basic live birth rate calculated for each assisted reproductive
technology performed by an assisted reproductive technology program
by dividing the number of pregnancies which result in live births by
the number of ovarian stimulation procedures attempted by such
program, and
(B) the live birth rate per successful oocyte retrieval procedure
calculated for each assisted reproductive technology performed by an
assisted reproductive technology program by dividing the number of
pregnancies which result in live births by the number of successful
2 13
oocyte retrieval procedures performed by such program.

The FCSRCA also includes a generalized definition section, which
currently sets forth three definitions for the purposes of the legislation as
a whole:
For purposes of sections 263a-1 to 263a-7 of this title:
(1) Assisted reproductive technology
The term "assisted reproductive technology" means all treatments or
procedures which include the handling of human oocytes or embryos,
including in vitro fertilization, gamete intrafallopian transfer, zygote
intrafallopian transfer, and such other specific technologies as the
Secretary may include in this definition, after making public any
proposed definition in such manner as to facilitate comment from any
person (including any Federal or other public agency).
(2) Embryo laboratory
The term "embryo laboratory" means a facility in which human
oocytes are subject to assisted reproductive technology treatment or
procedures based on manipulation of oocytes or embryos which are
subject to implantation.

213.

Id. § 263a-1(b).
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(3) Secretary
The term "Secretary" means the Secretary of Health and Human
214
Services.

Despite setting forth general parameters surrounding ART, the
FCSRCA, as currently written, is silent as to the obligation of a clinic to
report misimplantation or instances of human error in fertilization or
implantation. 25
B.

ProposedAdditions to the FCSRCA's ReportingRequirements and
Definitions Sections

This proposed addition to the legislation preserves the law's
reporting requirements as they currently stand, but calls for an additional
statistic to be included in the general reporting requirements of section
263a-1, which would then read "each assisted reproductive technology
program (as defined in section 263a-7 of this title) shall annually report
to the Secretary through the Centers for Disease Control known
laboratory misimplantation instances per year."2 16 As previously
explored, definitions relevant to the FCSRCA are included in section
263a-7.2 17 This portion of the legislation should be amended to include a
definition of "known misimplantation," so that the owner or operator of
the laboratory responsible for reporting correct annual information to the
CDC knows what "known misimplantation" would encompass, and
when it must be reported. 2 18 This Note proposes that "known
misimplantation" should be defined as "instances where an embryo was
implanted in an unintended patient," and that this definition be included
in the aforementioned reproduced section, following the preexisting
definitions included in the FCSRCA. 2 19

214. Id. § 263a-7.
215. See generally id. § 263a-1(a) (stipulating that only the success rate of each ART method
employed by such a clinic must be reported, along with the identity and certification status of the
reporting clinic).
216. See id. § 263a-1(a).
217. See generally id.
laboratory," and "secretary").

218.

§ 263a-7

(defining "assisted reproductive technology," "embryo

See generally id. (including the three existing definitions that will be retained). One

commentator has referred to instances of misimplantation as a subset of laboratory "mix-ups,"

which include instances of "mishandling sperm, eggs, or embryos," or "fertilizing eggs with [a]
stranger['s] sperm," or "implanting embryos into the wrong person." Fischer, supra note 19, at 207.
Defining "misimplantation" will also preserve the stated goal of the ART reporting system: to
provide information related to ART treatment and success rates. See generally CTRS. FOR DISEASE
CONTROL & PREVENTION, supra note 13, at 1.

219.

See § 263a-7.
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States Will Retain Their EnforcementAbilities

States have enforcement power over clinics that either fail to report
or misrepresent their clinics' data.2 20 Section 263a-4 of the FCSRCA
outlines certification revocation and suspension of embryo laboratories,

and mandates:
(a) In general: A certification issued by a State or an accreditation
organization for an embryo laboratory shall be revoked or suspended if
the State or organization finds, on the basis of inspections and after
reasonable notice and opportunity for hearing to the owner or operator
of the laboratory, that the owner or operator or any employee of the
laboratory(1) has been guilty of misrepresentation in obtaining the certification,
(2) has failed to comply with any standards under 263a-2 of this title
applicable to the certification, or
(3) has refused a request of the State or accreditation organization for
22
permission to inspect the laboratory, its operations, and records. 1

The changes proposed here will not impact the state's ability to
issue certification or the state's authority to delegate such responsibility
2 22
to the accreditation organization. By solely incorporating the proposed
reporting statistic of the known misimplantation instances, the
2 23
Though the
certification program standards would remain voluntary.
required reporting statistics would be enhanced, states would continue to
have the choice as to whether to opt into the CDC's model certification
program. 224 Likewise, states would continue to control the general
practice of medicine within their state, which would include licensing
and regulatory governance. 225
Moreover, the State or relevant accreditation organization would
continue to have the power to revoke a laboratory's license should the
laboratory fail to comply with the standards, which would now include
226
The current
misreporting or failing to report the misimplantation rate.
any
establish
not
"may
Secretary
DHHS
legislation mandates that the
regulation, standard, or requirement which has the effect of exercising
supervision or control over the practice of medicine in assisted
220. See supra Part II.E.
221. § 263a-4.
222. See id.; see also supra Part IV.B.
223. Implementation of the Fertility Clinic Success Rate and Certification Act of 1992-A
Model Program for the Certification of Embryo Laboratories, 64 Fed. Reg. 39,374, 39,374, 39,377
(July 21, 1999).
224. Id.
225. King, supra note 191, at 329.
226. § 263a-4.
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reproductive technology programs."22 7 This proposed solution does not
have the effect of control over the practice of medicine, as this
requirement would not impact a clinic's ability to conduct business in
the industry and is similar to the currently required annual reporting
statistics called for in section 263a-1. 22 8
D. Patients Will Retain Their Ability to Access This Report with
EnhancedInformation Included in the CDC'sPublication
In requiring a misimplantation statistic to be reported to and
published by the CDC, the statute's goal of helping patients "make
informed decisions about ART" by providing them with heightened
information will not change.2 29 The CDC's annual report currently aims
to help hopeful parents find an ART clinic in their desired geographic
area, which, in turn, allows the parents and providers to meet and discuss
the individual's medical situation, needs, and likelihood of reproductive
success.23 0 The report will still be accessible to and used by the general
public by being presented in "an easily understandable form." 231
The FCSRCA was intended to enable consumer-patients exploring
clinics within the United States to make more informed decisions about
the ART options available to them by arming the public with
information related to each clinic's success rate, while simultaneously
incorporating a model certification program that the states could choose
to adopt.23 2 Providing the public with known misimplantation statistics
will not derail the intent of the FCSRCA, but instead will enhance it, as
the statute will continue to require "[s]tates and accreditation
organizations to include the necessary explanatory information for the
public" to use in interpreting the findings. 2 3 The CDC currently
provides literature regarding the access of the annual report to aid the
public in better understanding the information provided.2 4 The CDC
provides certain resources and poses considerations if the consumer is

227.
228.

§ 263a-2(i)(1).

230.

See generally § 263a-1 (stipulating the annual reporting statistics currently required).
CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 13, at 1.
Id. at 5.

231.

Id. at 1. Likewise, this report will continue to be "informative and helpful to [those]

229.

considering an ART procedure" at a particular clinic. Id.
232.

Adamson, supra note 21, at 731.

233. Implementation of the Fertility Clinic Success Rate and Certification Act of 1992-A
Model Program for the Certification of Embryo Laboratories, 64 Fed. Reg. 39,374, 39,378 (July 21,
1999).
234. Tutorial for Using the ART Report, CTRS. FOR DISEASE CONTROL & PREVENTION,
https://www.cdc.gov/art/patientResources/using.html (Feb. 17, 2017) (outlining, for the general
public, what information is included in the report and the relevant "hints" to reviewing the report).
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planning to use donor eggs or embryos, along with varying
235
recommendations if the hopeful parent plans to use their own eggs
The CDC also breaks down the tutorial into five different sections to
guide users in finding the answers to questions they may have when
seeking out information included in the report.2 3 6 None of these
suggestions, resources, or recommendations would need to be modified
if the proposed changes to the legislation were incorporated, meaning
this valuable consumer resource will not be rendered inoperable upon
2 37
adoption of the above-mentioned proposed changes.
Currently, the CDC is considering adding more required reporting
statistics to the FCSRCA, along with expanding the required reporting
laboratories. 238 The following provisions are under consideration for
addition to the FCSRCA: reporting of a patient's demographic
information where the patient is using donor eggs but does not carry the
pregnancy; reporting of oocyte source and carrier information such as
height, weight, smoking history, prior ART cycles, and pregnancy
history; and requiring clinics that are under contract with external ART
laboratories to report their data. 239 To this end, the CDC is currently
seeking written comments on the proposed additions or modifications
from any interested persons or organizations, which would be included
in the public record and subject to review and consideration by the
CDC. 240
The CDC's attempt to seek comment on these modifications is
consistent with the responsibility set forth in section 263a-1 of the
FCSRCA, which states that the DHHS Secretary, who oversees the
CDC, shall "consult with appropriate consumer and professional
organizations with expertise in using, providing, and evaluating
professional services and embryo laboratories associated with assisted
reproductive technologies."2 1 The CDC will respond to the recent
comments in a manner similar to that in which it responded to comments
235. See id. (suggesting that patients using donor eggs and embryos should focus on sections
one and four of the report, while those using their own eggs should concentrate on sections one and
two of the report).
236. See id. (denoting section one as an overview, section two as concerning ART cycles using
fresh nondonor eggs or embryos, section three as concerning ART cycles using frozen nondonor
eggs or embryos, section four as concerning ART cycles using donor eggs, and section five as
concerning ART trends).

237. See id.
238. Reporting of Pregnancy Success Rates from Assisted Reproductive Technology (ART)
Programs; Proposed Additional Data Collection Fields; Request for Comment, 84 Fed. Reg. 59,814,
59,814-15 (Nov. 6, 2019).
239. Id.
240. Id. at 59,814.
241. See 42 U.S.C. § 263a-1(c).
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prior to the initial implementation of the FCSRCA. 242 The amendment
proposed in this Note could also be subject to notice-and-comment. 2 3
V.

CONCLUSION

Fertility treatments involving ART have quickly increased in
popularity in the United States over the past forty years.244 Many public
figures have taken advantage of the medical advancements surrounding
fertility,245 with IVF being the most popular and widely used ART
method as of today. 246 Despite the popularity of IVF, its long-term
effects on women who undergo the treatment are still unknown. 24 7 The
increased usage of IVF has unfortunately resulted in life-changing errors
that have affected both the birth and genetic parents and will inevitably
impact the children derived from misimplantation. 248
After the federal government first responded to the increased use of
ART technology by enacting the FCSRCA, 24 9 state legislatures were left
to fill in the gaps with a varying patchwork approach. 2 s0 As a result, this
industry is governed with an uneven hand throughout the United
States. 25' Some commentators have considered the FCSRCA and
52
supplemental legislation or self-regulation to be an overall success, 2
23
It is
while others remain critical of the collective shortcomings.

242. See Implementation of the Fertility Clinic Success Rate and Certification Act of 1992-A
Model Program for the Certification of Embryo Laboratories, 64 Fed. Reg. 39,374, 39,376-82 (July
21, 1999) (including a summary of comments the CDC received from interested individuals and
organizations and the CDC's accompanying response to each comment).
243. See generally Reporting of Pregnancy Success Rates from Assisted Reproductive
Technology (ART) Programs; Proposed Additional Data Collection Fields; Request for Comment,
84 Fed. Reg. at 59,814 (broadcasting the CDC's desire to obtain comments and reviews of proposed
data collection fields and the modification of ART programs); see also National ART Surveillance,
supra note 179 (outlining the CDC's ongoing partnership with ASRM and SART in producing the
yearly FCSRCA report and facilitating public health communication).
244. See supra Part I.A. This popularity can also be observed in what is now colloquially
known as "Cocktails and Cryo" parties, which are hosted by clinics in an effort to attract new

business and normalize the process of patients freezing their eggs for later use in conceiving a child.
Grose, supra note 128, at 2.

245. See supra Part I.B.
246.

See supra note 36 and accompanying text.

247. See Maya Dusenbery, What We Don't Know - And Why, N.Y. TIMES MAG., Nov. 10,
2019, at 11 ("[I]t's all but impossible to know which observed health risks are due to the fertility
treatments and which are a result of the underlying cause of the infertility itself.").

248.
249.
250.
251.
252.
industry
253.

See supraPart HI.A.
See supra Part I.D.
See supra Part II.E.
See supra Part IHI.D.
See Ollove, supra note 183 (featuring ASRM lobbyist Sean Tipton, who characterizes the
as heavily regulated).
See Fischer, supra note 19, at 202 ("[T]he current state of legislative redundancy and gaps

Published by Scholarly Commons at Hofstra Law, 2021

31

Hofstra Law Review, Vol. 49, Iss. 2 [2021], Art. 7

566

HOFSTRA LAW REVIEW

[Vol. 49:535

undisputed, however, that there is currently no definite way for potential
parents to know if the clinic they are considering has previously caused
an embryo's misimplantation because the industry is allowed to rely on a
clinic's voluntary compliance with the FCSRCA standards 254 and
self-regulation." The ability of clinics to rely on best practices,
self-regulation, and self-reporting has earned the United States' fertility
industry a reputation comparable to the "wild west." 2 6 Dov Fox,
Professor of Law at the University of San Diego, describes unregulated
misimplantation occurrences succinctly: "We really have no idea how
often this sort of thing happens where sperm fertilizes the wrong egg or
embryos are switched. But cases that appear in courts and reports
suggest that it happens a whole lot more often than you might think." 257
As such, the FCSCRA should be revitalized and amended to require
clinics operating within the United States to report statistics that disclose
these grave, life-changing errors.2 58 Incorporating the proposed
requirement will ensure the states retain their police powers, guaranteed
under the Tenth Amendment, 2" and will likewise empower the general
public by providing hopeful ART consumers with access to more
transparent information needed to make decisions regarding their future
children and family planning.2 6 The intentions of the FCSRCA, as it
was originally enacted, will be preserved, 26 but the access of the end
users-hopeful parents-will be enhanced, thereby improving the
increasingly popular ART field as a whole. 2 62

creates negative incentives for assisted reproduction providers and poses risks for their customers of
their services."). See also Breen, supra note 163 (explaining that fertility centers in the United
States "operate free of almost any regulation at all").
254. See supra Part HB.
255. See supra Part III.C. Additionally, the industry relies on patients who have been
victimized by misimplantation to come forward to the press. See supra Part I.A.
256. See Fischer, supranote 19, at 202.
257. Breen, supra note 163.
258. See supra Part IV.B. This solution will be a step forward in strengthening the ART
industry by realigning the United States' standard slightly closer to that of the United Kingdom
model cited as "the forefront of the ART field." Fischer, supra note 19, at 217.
259. See supraPart I.C.
260. See supra Part I.D. The report will continue to be "a helpful starting point for consumers
to obtain information and consider their options." CTRS. FOR DISEASE CONTROL & PREVENTION,

supra note 13, at 5.
261. See supraPart IV.D.
262. See supraPart IV.
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